EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Immunomodulatory therapy of chikungunya arthritis: systematic review and meta-analysis

José Kennedy Amaral, Robert Taylor Schoen, Clifton O Bingham, Aileen Chang, Estelita Lima Cândido

Journal of Travel Medicine · 01.10.2025 · 32 (6)

DOI: 10.1093/jtm/taaf067 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Travel Medicine, online erschienen am 14.07.2025. Verfasst von José Kennedy Amaral und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Health Sciences, Faculty of Medicine, Federal University of Cariri, 284 Divino Salvador Street, 63090-000 Barbalha, Ceará, Br…. Hauptthemen laut MEDLINE: Chikungunya Fever, Methotrexate, Immunomodulating Agents, Arthritis, Infectious. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chikungunya virus (CHIKV) infection can lead to chronic musculoskeletal complications, including persistent arthritis that resembles autoimmune inflammatory conditions. These symptoms have been reported both in endemic populations and in international travellers, with substantial functional and economic consequences.

Objective

This systematic review and meta-analysis aimed to assess the efficacy and safety of immunomodulatory therapies in chikungunya-related arthritis.

Methods

A systematic search was conducted in PubMed, Scopus, Cochrane, Web of Science, SciELO and LILACS. Risk of bias was assessed using RoB 2.0 for randomized trials, the Newcastle-Ottawa Scale for observational studies and the Joanna Briggs Institute Checklist for case series. A random-effects meta-analysis was performed due to significant heterogeneity (I2 > 97%).

Results

Eleven studies comprising 742 patients met the inclusion criteria. Methotrexate (MTX) was the most studied immunomodulator. The meta-analysis showed a mean reduction in disease activity score of 2.67 (95% CI: 1.84–3.49, P < 0.001, I2 = 97.0%) and a decrease in Visual Analogue Scale pain scores of 4.31 (95% CI: 2.56–6.06, P < 0.001, I2 = 99.1%). Subgroup analysis suggested greater pain reduction in short-term studies. No severe adverse events were reported, but long-term safety data are limited.

Conclusions

Immunomodulatory therapy, particularly MTX, may provide symptom relief in chikungunya arthritis. These findings are relevant not only for endemic settings but also for travel medicine, as chikungunya-related arthritis has been increasingly reported in travellers. However, high study heterogeneity and the lack of randomized trials limit definitive conclusions. Future research should focus on standardizing outcome measures, biomarker-driven patient selection and long-term safety assessments. Clinicians treating returning travellers with chronic joint symptoms should consider post-CHIKV arthritis as part of the differential diagnosis and be aware of potential treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverMethotrexateImmunomodulating AgentsArthritis, InfectiousArthritisHumansChikungunya virusTravel

Stichwörter der Autor:innen

Chikungunyaarthritischronic inflammationimmunosuppressantsmeta-analysismethotrexatesystematic review

Substanzen

MethotrexateImmunomodulating Agents

Autor:innen und Institutionen

  • Postgraduate Program in Health Sciences, Faculty of Medicine, Federal University of Cariri, 284 Divino Salvador Street, 63090-000 Barbalha, Ceará, Brazil.
  • Section of Rheumatology, Allergy, and Immunology, Yale University School of Medicine, 15 York Street, New Haven, CT 06510 USA.
  • Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, 5200 Eastern Ave, Baltimore, MD 21224, USA.
  • Department of Medicine, George Washington University, 2150 Pennsylvania Ave Suite 5-416, Washington, DC 20037, USA.

Zitieren

APA

Amaral, J. K., Schoen, R. T., Bingham, C. O., Chang, A., & Cândido, E. L. (2025). Immunomodulatory therapy of chikungunya arthritis: systematic review and meta-analysis. Journal of Travel Medicine, 32(6). https://doi.org/10.1093/jtm/taaf067

Vancouver

Amaral JK, Schoen RT, Bingham CO, Chang A, Cândido EL. Immunomodulatory therapy of chikungunya arthritis: systematic review and meta-analysis. Journal of Travel Medicine. 2025;32(6). doi:10.1093/jtm/taaf067

BibTeX
@article{Amaral2025,
  author = {Amaral, José Kennedy and Schoen, Robert Taylor and Bingham, Clifton O and Chang, Aileen and Cândido, Estelita Lima},
  title = {Immunomodulatory therapy of chikungunya arthritis: systematic review and meta-analysis},
  journal = {Journal of Travel Medicine},
  year = {2025},
  volume = {32},
  number = {6},
  doi = {10.1093/jtm/taaf067}
}
Kostenlos starten →